Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


31st week of 2016 patent applcation highlights part 23
Patent application numberTitlePublished
20160221995SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-- METHYLPYRIDIN-2-YL) BENZOIC ACID2016-08-04
20160221996PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR2016-08-04
20160221997BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS2016-08-04
20160221998HETEROCYCLIC AMIDE COMPOUND AND HERBICIDE2016-08-04
20160221999COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS2016-08-04
20160222000VINYL AUTOTAXIN INHIBITOR COMPOUNDS2016-08-04
20160222001COMT Inhibiting Methods and Compositions2016-08-04
20160222002TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF2016-08-04
20160222003Novel Phtalazinone Derivatives and Manufacturing Process Thereof2016-08-04
20160222004THIAZOLE AND OXAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS2016-08-04
201602220052-(HETERO)ARYL-BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF ASPARAGIME EMETHYL TRANSFERASE2016-08-04
201602220063-(4-Ethylnylphenyl) Pyridopyrimidinone Compounds and Process for Preparation Thereof Useful As Potential Anticancer Agents2016-08-04
20160222007Novel Cyclopropabenzofuranyl Pyridopyrazinediones2016-08-04
20160222008FORMULATIONS PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 22016-08-04
20160222009INHIBITOR COMPOUNDS2016-08-04
201602220104-AMINO-IMIDAZOQUINOLINE COMPOUNDS2016-08-04
20160222011COMT Inhibiting Methods and Compositions2016-08-04
20160222012Heterocyclic compounds as inhibitors of class I PI3KS2016-08-04
20160222013NOVEL BENZODIAZEPINE DERIVATIVES2016-08-04
20160222014COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS2016-08-04
20160222015TRICYCLIC GYRASE INHIBITORS2016-08-04
20160222016HETEROCYCLIC COMPOUNDS AND USES THEREOF2016-08-04
20160222017PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS2016-08-04
20160222018SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C- FUNCTIONALIZED DERIVATIVES THEREOF2016-08-04
20160222019QUINAZOLIN-4 (3H)- ONE DERIVATIVES USED AS P13 KINASE INHIBITORS2016-08-04
20160222020NOVEL TRICYCLIC COMPOUNDS2016-08-04
20160222021ARYL ETHER-BASE KINASE INHIBITORS2016-08-04
201602220223-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS2016-08-04
20160222023NOVEL MONOTHIOL MUCOLYTIC AGENTS2016-08-04
20160222024S-ENANTIOMER OF TETRACYCLIC INDOLE DERIVATIVE AS PBR LIGANDS2016-08-04
20160222025SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH2016-08-04
20160222026Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors2016-08-04
20160222027POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]I- MIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF2016-08-04
201602220283-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS2016-08-04
20160222029A PROCESS FOR THE PREPARATION OF INTERMEDIATE FOR THE PREPARATION OF OSELTAMIVIR PHOSPHATE2016-08-04
20160222030Cyclopentylbenzamide Derivatives and their Use for the Treatment of Psychotic and Cognitive Disorders2016-08-04
20160222031EPIDITHIODIOXOPIPERAZINE COMPOUND OR ITS DERIVATIVES, AND THE USE THEREOF2016-08-04
20160222032C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE2016-08-04
20160222033THIAZOLOPYRIMIDINONES AND METHODS OF USE THEREOF2016-08-04
20160222034HEPATITIS C VIRUS INHIBITORS2016-08-04
20160222035PRECISE THREE-DIMENSIONAL SUPRAMACROMOLECULE INTERCONVERSIONS2016-08-04
20160222036TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES AND METHODS OF USE THEREOF2016-08-04
20160222037USE OF CYCLOHEXA-2,5-DIEN-1-YL-SILANES AS PRECURSORS FOR GASEOUS HYDROSILANES2016-08-04
20160222038NOVEL, EASILY SYNTHESIZABLE, SPONTANEOUSLY WATER-SOLUBLE, ESSENTIALLY VOC-FREE, ENVIRONMENTALLY FRIENDLY (METH)ACRYLAMIDO-FUNCTIONAL SILOXANOL SYSTEMS, PROCESS FOR PREPARATION THEREOF AND USE2016-08-04
20160222039SPINTRONIC MATERIALS AND SPINTRONIC DEVICES INCLUDING THE SPINTRONIC MATERIALS2016-08-04
20160222040PROCESS FOR STABILIZING HYDROCYANATION CATALYST2016-08-04
20160222041BIARYL LIGANDS2016-08-04
20160222042NOVEL PHOSPHINES, SYNTHESIS THEREOF AND THEIR USE IN CATALYSIS2016-08-04
20160222043METALLOINSERTOR CONJUGATES2016-08-04
20160222044ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME2016-08-04
20160222045HIGH VALUE LIGNIN DERIVATIVES, POLYMERS, AND COPOLYMERS AND USE THEREOF IN THERMOPLASTIC, THERMOSET, COMPOSITE, AND CARBON FIBER APPLICATIONS2016-08-04
20160222046CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]- BENZENE AND PREPARATION METHOD THEREOF2016-08-04
20160222047C-ARYL GLUCOSIDE DERIVATIVE, PREPARATION METHODS THEREOF, AND MEDICAL APPLICATIONS THEREOF2016-08-04
20160222048AUTOMATED CARBOHYDRATE SYNTHESIS2016-08-04
20160222049Aminoglycoside Antibiotics with Reduced Ototoxicity2016-08-04
20160222050MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF2016-08-04
20160222051Self-Assembling Oligonucleotides and Methods2016-08-04
20160222052DEUTERATED COMPOUNDS2016-08-04
20160222053POLYMORPHIC FORM OF SODIUM HYODEOXYCHOLATE (NAHDC) AND ITS PREPARATION PROCESS2016-08-04
20160222054PH SWITCHABLE REAGENTS AND METHODS FOR THEIR USE2016-08-04
20160222055METHOD FOR PRODUCING PROTEIN BY PRECIPITATION2016-08-04
20160222056SUBSTITUTED PHENYLALANINE DERIVATIVES2016-08-04
20160222057COMPOUNDS FOR PROTEASOME ENZYME INHIBITION2016-08-04
20160222058BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME2016-08-04
20160222059METHOD FOR PREPARING EPTIFIBATIDE2016-08-04
20160222060Immunomodulators2016-08-04
20160222061Polymyxin Derivatives and Their Use in Combination Therapy Together with Different Antibiotics2016-08-04
20160222062Cyclic Amino Acid Molecules And Methods Of Preparing The Same2016-08-04
20160222063NOVEL POLYPEPTIDES2016-08-04
20160222064HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE2016-08-04
20160222065ANTIBODY LIKE PROTEIN2016-08-04
20160222066NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS2016-08-04
20160222067NOVEL AAV'S AND USES THEREOF2016-08-04
20160222068CONSTRUCTS FOR EXPRESSING BIOLOGICAL MOLECULES THAT INTEGRATE INTO BACTERIAL MICROCOMPARTMENTS2016-08-04
20160222069PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES2016-08-04
20160222070COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS2016-08-04
20160222071ANALOGS OF SODIUM CHANNEL PEPTIDE TOXIN2016-08-04
20160222072Universal Protein Tag for Double Stranded Nucleic Acid Delivery2016-08-04
20160222073OPSIN POLYPEPTIDES AND METHODS OF USE THEREOF2016-08-04
20160222074ALPHA-FETOPROTEIN "RING AND TAIL" PEPTIDES2016-08-04
20160222075PRODUCTION OF GLYCOPROTEINS USING MANGANESE2016-08-04
20160222076HEPCIDIN ANALOGUES AND USES THEREOF2016-08-04
20160222077COMPOSITION COMPRISING PEPTIDE DERIVED FROM ADIPONECTIN2016-08-04
20160222078VIP FRAGMENTS AND METHODS OF USE2016-08-04
20160222079Long-Acting Blood Sugar Decreasing Fusion Protein2016-08-04
20160222080MULTIPLE TARGET T CELL RECEPTOR2016-08-04
20160222081Fc-BINDING PROTEIN, METHOD FOR PRODUCING SAID PROTEIN, AND ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHODS FOR PURIFYING AND IDENTIFYING ANTIBODY USING SAID ADSORBENT2016-08-04
20160222082FUSION PROTEIN2016-08-04
20160222083ANTI-ENDOGLIN ANTIBODIES AND KNOCKIN MICE EXPRESSING NOVEL HUMAN/MOUSE CHIMERIC ENDOGLIN2016-08-04
20160222084Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies2016-08-04
20160222085COMPOSITIONS AND METHODS FOR MODULATING THROMBIN GENERATION2016-08-04
20160222086Conjugated Factor VIII Molecules2016-08-04
20160222087ALBUMIN VARIANTS2016-08-04
20160222088RECOMBINANT CLUSTERIN AND USE THEREOF IN THE TREATMENT AND PREVENTION OF DISEASE2016-08-04
20160222089COMPOSITIONS COMPRISING THE NC2 DOMAIN OF COLLAGEN IX AND METHODS OF USING SAME2016-08-04
20160222090NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES2016-08-04
20160222091NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES2016-08-04
20160222092NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES2016-08-04
20160222093NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES2016-08-04
20160222094Inducible Eukaryotic Expression System2016-08-04
Website © 2025 Advameg, Inc.